Abnormal oxidative metabolism of estradiol in women with breast cancer.
about
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basisEndocrine disruptors and human health--is there a problem? An updateUnderstanding the human health effects of chemical mixtures.Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolismSequence diversity and haplotype structure at the human CYP3A cluster2-Methoxyestradiol, a promising anticancer agentThe role of female hormones on lung function in chronic lung diseases.Estrogen metabolism as a risk factor for head and neck cancer.Chromosomal organization of the cytochrome P450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylaseCovalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localizationUse of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.Comparison of estrogens and estrogen metabolites in human breast tissue and urine.Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletesThe role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast.Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment.Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals.Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.Is there an association between exposure to environmental estrogens and breast cancer?A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancerEffects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer riskInduction of 16alpha-/2-hydroxyestrone metabolite ratios in MCF-7 cells by pesticides, carcinogens, and antiestrogens does not predict mammary carcinogens.Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancerUrinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up.Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy TrialTotal dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal womenCatalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous SubstratesCirculating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.Urinary estrogen metabolites in women at high risk for breast cancer.17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.Inhibitory effects of Chinese nutritional herbs in isogenic breast carcinoma cells with modulated estrogen receptor function.Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal womenDiindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans.Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer?Epidemiologic studies of estrogen metabolism and breast cancer.16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer.Indole-3-carbinol. A novel approach to breast cancer prevention.
P2860
Q24641921-4EF1B80D-2F96-4C3D-9FA2-3564B1E26750Q24670574-A37350C2-E078-4E18-9070-D439C385F423Q24811691-9D515ACD-B1D9-4D1A-9336-9DB9E7DA9528Q28241653-F058520D-89FC-46E0-821B-4B9310F7E2F3Q28284189-BC20692B-5DF0-4A27-AD90-79EA49C43223Q28611188-51359892-CA30-496C-89EF-2F7EF6799590Q31015647-F9A42B6C-5013-4BCC-8030-A75F9DF54051Q32157172-28D8E6AE-4762-4867-9472-977E98FCDEC6Q33567320-004B922B-F3D3-4857-88D8-B504432F0D1BQ33658358-C48E0B83-7DF5-44F9-BD66-3C5DD8C82A18Q33827813-F3195B79-6663-46FC-9E3E-C398F1D43189Q33847977-622521E4-6190-48AD-9E9F-BECDE3B793ECQ34068274-A57E3530-C431-47C1-84B5-7711F989E99FQ34201187-3960365C-6A18-49F6-9600-A35608D26FA2Q34291721-62C44107-F4EE-4537-A581-FA51FAD1F21CQ34504689-772D136E-55DA-4C0B-8122-A73342D5FCC3Q34574141-78AA62B5-5C3A-4810-92C7-DA65D0C86DA4Q34638041-E9F0F628-43E5-498A-B0E7-6EED13CCE02CQ34638137-E7D62D84-7127-4A20-BD6F-211D10349CE2Q34638144-C589CBE4-DC5D-4F56-8E2A-7CD08B96553FQ34638174-A7396024-EA07-4842-A12D-B4B96349C5C8Q34832163-82931535-44D3-45A9-8CB6-482CF28E0557Q34936520-E710171C-D0D1-4E8F-9F5C-18F8BA5AF747Q35620661-B603A005-1896-42D4-BD1E-87315154A88DQ35729908-AA77521D-7A51-4F69-AD6D-440155A9BBC4Q36115140-F75A357C-4E22-45ED-81F5-DC1D355B018AQ36385015-A753378F-3583-4D5E-B538-157B24A88F65Q36799332-10835D40-01B2-407B-A5D8-29329EA08A0AQ36852521-CE4FE12C-AB37-4D54-994B-7E035693F91AQ36925454-DB8EC63E-52B4-4845-A90C-C407DB635B0BQ37329197-353F3F2F-06C8-48EB-B7A7-19C93B177BFDQ37363103-EAD43659-B9BB-46C8-9ED2-72E218245D8EQ37407255-0529CA18-86F9-4AF0-9448-AAC0624279F8Q37438330-65DBA740-0531-435E-B2B9-1521FA698D11Q37440864-A8B94CEF-F145-44BD-AFDF-EE8E56C08DEDQ37543007-D6ED07C5-A6B6-42C5-82A4-1A15D53AC6BBQ38215559-8A9A3BE0-A061-41DF-A8FA-2907F40A0C76Q38366037-AEB8425C-45E1-4576-B8BF-3F33FF2D705EQ39503292-2DB2B950-FB72-4AC2-8100-66A690E9570DQ40925469-B269AA03-0349-425B-A538-C7D03EC49E88
P2860
Abnormal oxidative metabolism of estradiol in women with breast cancer.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@ast
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@en
type
label
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@ast
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@en
prefLabel
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@ast
Abnormal oxidative metabolism of estradiol in women with breast cancer.
@en
P2093
P2860
P356
P1476
Abnormal oxidative metabolism of estradiol in women with breast cancer
@en
P2093
P2860
P304
P356
10.1073/PNAS.79.9.3047
P407
P577
1982-05-01T00:00:00Z